
Elegent Pharmaceuticals Limited - Loans (Charges)
Founded in 1990 and headquartered in Maharashtra, India.

Founded in 1990 and headquartered in Maharashtra, India.
Data last updated:
Elegent Pharmaceuticals Limited has 8 charges registered with the Registrar of Companies: 8 open charges worth Rs 20.51 Cr. The largest open charges are held by Bank Of Baroda and Union Bank Of India. The most recent charge was created on 09 Feb 1996 in favour of Union Bank Of India for Rs 5.00 M and is open.
₹20.51 crore
-
2
Bank Of Baroda
Modification
31 Jan 2008
₹5.95 cr
| Charge Id | Lender | Amount | Creation Date | Last Modification Date | Satisfaction Date | Status |
|---|---|---|---|---|---|---|
| 90352425 View Details | Union Bank Of India | ₹ 0.50 | 09 Feb 1996 | - | - | Open |
| 80044191 View Details | Bank Of Baroda | ₹ 1.50 | 30 Jun 1995 | - | - | Open |
| 90352324 View Details | Bank Of Baroda | ₹ 0.50 | 25 Feb 1995 | 31 Jan 2008 | - | Open |
| 90352294 View Details | Union Bank Of India | ₹ 0.80 | 24 Oct 1994 | 30 Jun 1995 | - | Open |
| 90352292 View Details | Bank Of Baroda | ₹ 5.26 | 12 Oct 1994 | 31 Jan 2008 | - | Open |
| 90352278 View Details | Bank Of Baroda | ₹ 0.06 | 09 Aug 1994 | 31 Jan 2008 | - | Open |
| 90352237 View Details | Bank Of Baroda | ₹ 5.95 | 06 Mar 1994 | 31 Jan 2008 | - | Open |
| 90352236 View Details | Bank Of Baroda | ₹ 5.95 | 05 Mar 1994 | 31 Jan 2008 | - | Open |
Premium access Charge documents and asset detailsThe filed charge documents and the assets pledged under each charge are in the company report.
Verified entity values are shown only after access is granted. | ||||||
A charge is a security interest a company creates over its assets in favour of a lender. An open charge is still outstanding; a satisfied charge has been repaid and closed with the Registrar. Under the Companies Act, 2013 every charge must be registered within thirty days of creation (Form CHG-1, or CHG-9 for debentures) and its satisfaction reported within thirty days of repayment (Form CHG-4). Amounts are as filed with the MCA.